News
A new study has revealed significant cost disparities and information challenges faced by fertility patients in the UK. The research explores the financial burden of fertility treatment add-ons and highlights growing concerns over the reliability of information provided by clinics. The study, based on a survey of 304 current and prospective IVF patients, reveals that [...]
A new study has uncovered a new wat to select viable sperm and prolong their viability in the lab, reducing one source of variability during the process - potentially helping to improve the success of IVF. The success of IVF depends on many factors, one of which is sperm viability. For the study, a group [...]
With around 1 in 10 women affected by endometriosis, providing fertility support can improve wellbeing, productivity, and retention. Q&A with Natasha Fernando, GP & Medical Director, Medichecks In an increasingly diverse workplace, understanding and supporting the health challenges faced by employees is crucial. One condition that remains under the radar for many businesses is endometriosis, [...]
Biotech company Anixa Biosciences has received a Notice of Allowance for a key patent application covering its ovarian cancer vaccine technology from the United States Patent and Trademark Office (USPTO). Anixa's ovarian cancer vaccine uses a novel approach to preventing and treating ovarian cancer, particularly among high-risk populations such as those carrying BRCA mutations or [...]
Women with ongoing urinary incontinence could avoid invasive bladder pressure tests, as new research shows that a range of non-invasive assessments work just as well in guiding treatment. The UK study is the world’s first randomised controlled trial of the clinical and cost-effectiveness of invasive urodynamics testing. Lead researcher Professor Mohamed Abdel-Fattah is Director of [...]
Women with blood pressure levels in a range considered clinically normal during pregnancy but no mid-pregnancy drop in blood pressure face an increased risk of developing hypertension in the five years after giving birth, a new study shows. These women, about 12 per cent of the population studied, would not be flagged as high-risk by [...]
GE HealthCare has launched the Invenia Automated Breast Ultrasound (ABUS) Premium, a 3D ultrasound offering advanced AI features to drive faster, reproducible screening and streamline exam readings on patients with dense breasts. Approximately 71 per cent of cancers occur in dense breasts. According to studies across the U.S. and Europe, 40 per cent of women [...]
Menopause is associated with a decline in oestrogen, which increases visceral fat mass and decreases bone density, muscle volume, and muscle strength. This can lead to immobility and related health problems. A new study suggests there may be an easy way to predict which women are most at risk - low creatinine-to-cystatin C ratios. Women [...]
Mammograms used in combination with AI may reveal much more than cancer, but can also be used to assess the amount of calcium build up in the arteries within breast tissue - an indicator of cardiovascular health, a new study shows. While breast artery calcifications can be seen on mammogram images, radiologists do not typically [...]
Women's precision healthcare company Evvy is launching Fertility Insights within its flagship Vaginal Microbiome Test, which provides insights on the role of the vaginal microbiome in fertility. The vaginal microbiome is the community of bacteria, fungi, and viruses that live in the vagina - and emerging research highlights its crucial role in reproductive health. An [...]
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.
















